Logo image of IBTA

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

NYSE:IBTA - New York Stock Exchange, Inc. - US4510511060 - Common Stock - Currency: USD

49.36  -0.83 (-1.65%)

After market: 49.36 0 (0%)

Fundamental Rating

5

Taking everything into account, IBTA scores 5 out of 10 in our fundamental rating. IBTA was compared to 97 industry peers in the Media industry. IBTA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IBTA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year IBTA was profitable.
IBTA had a positive operating cash flow in the past year.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

IBTA has a Return On Assets of 10.13%. This is amongst the best in the industry. IBTA outperforms 93.81% of its industry peers.
The Return On Equity of IBTA (15.03%) is better than 84.54% of its industry peers.
IBTA's Return On Invested Capital of 5.09% is fine compared to the rest of the industry. IBTA outperforms 64.95% of its industry peers.
Industry RankSector Rank
ROA 10.13%
ROE 15.03%
ROIC 5.09%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 -50 100 150

1.3 Margins

IBTA has a Profit Margin of 18.72%. This is amongst the best in the industry. IBTA outperforms 93.81% of its industry peers.
IBTA has a Operating Margin (7.60%) which is in line with its industry peers.
IBTA has a better Gross Margin (86.35%) than 96.91% of its industry peers.
Industry RankSector Rank
OM 7.6%
PM (TTM) 18.72%
GM 86.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBTA is destroying value.
The number of shares outstanding for IBTA has been increased compared to 1 year ago.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 5.08 indicates that IBTA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.08, IBTA belongs to the top of the industry, outperforming 88.66% of the companies in the same industry.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.08
ROIC/WACC0.57
WACC8.93%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

IBTA has a Current Ratio of 2.85. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
IBTA's Current ratio of 2.85 is amongst the best of the industry. IBTA outperforms 87.63% of its industry peers.
A Quick Ratio of 2.85 indicates that IBTA has no problem at all paying its short term obligations.
IBTA has a better Quick ratio (2.85) than 87.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.85
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.05% over the past year.
Looking at the last year, IBTA shows a quite strong growth in Revenue. The Revenue has grown by 14.75% in the last year.
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%196.16%
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.3%

3.2 Future

IBTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 125.82% yearly.
IBTA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.90% yearly.
EPS Next Y710.63%
EPS Next 2Y225.89%
EPS Next 3Y125.82%
EPS Next 5YN/A
Revenue Next Year2.28%
Revenue Next 2Y8.43%
Revenue Next 3Y10.9%
Revenue Next 5YN/A

3.3 Evolution

IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 259.79, the valuation of IBTA can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as IBTA.
The average S&P500 Price/Earnings ratio is at 28.10. IBTA is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 32.05 indicates a quite expensive valuation of IBTA.
IBTA's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.74. IBTA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 259.79
Fwd PE 32.05
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IBTA is valued a bit more expensive than the industry average as 61.86% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBTA indicates a somewhat cheap valuation: IBTA is cheaper than 63.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.78
EV/EBITDA 31.45
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

IBTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBTA's earnings are expected to grow with 125.82% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y225.89%
EPS Next 3Y125.82%

More info and screens

0

5. Dividend

5.1 Amount

IBTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBOTTA INC-CL A

NYSE:IBTA (5/5/2025, 8:17:31 PM)

After market: 49.36 0 (0%)

49.36

-0.83 (-1.65%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-14 2025-05-14
Inst Owners48.36%
Inst Owner Change1.76%
Ins Owners17.92%
Ins Owner Change-0.08%
Market Cap1.46B
Analysts76
Price Target56.48 (14.42%)
Short Float %17.07%
Short Ratio3.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.53%
Min EPS beat(2)42.28%
Max EPS beat(2)46.79%
EPS beat(4)2
Avg EPS beat(4)8.43%
Min EPS beat(4)-52.55%
Max EPS beat(4)46.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.06%
Min Revenue beat(2)-6.93%
Max Revenue beat(2)2.8%
Revenue beat(4)2
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-6.93%
Max Revenue beat(4)2.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.34%
PT rev (3m)-33.55%
EPS NQ rev (1m)-94.73%
EPS NQ rev (3m)-97.67%
EPS NY rev (1m)-20.02%
EPS NY rev (3m)-42.72%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-9.78%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-12.1%
Valuation
Industry RankSector Rank
PE 259.79
Fwd PE 32.05
P/S 3.97
P/FCF 13.78
P/OCF 12.57
P/B 3.19
P/tB 3.19
EV/EBITDA 31.45
EPS(TTM)0.19
EY0.38%
EPS(NY)1.54
Fwd EY3.12%
FCF(TTM)3.58
FCFY7.26%
OCF(TTM)3.93
OCFY7.96%
SpS12.44
BVpS15.49
TBVpS15.49
PEG (NY)0.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.13%
ROE 15.03%
ROCE 5.89%
ROIC 5.09%
ROICexc 19.33%
ROICexgc 19.33%
OM 7.6%
PM (TTM) 18.72%
GM 86.35%
FCFM 28.79%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 126.25%
Cap/Sales 2.78%
Interest Coverage 10.81
Cash Conversion 321.95%
Profit Quality 153.79%
Current Ratio 2.85
Quick Ratio 2.85
Altman-Z 5.08
F-Score6
WACC8.93%
ROIC/WACC0.57
Cap/Depr(3y)126.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%196.16%
EPS Next Y710.63%
EPS Next 2Y225.89%
EPS Next 3Y125.82%
EPS Next 5YN/A
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.3%
Revenue Next Year2.28%
Revenue Next 2Y8.43%
Revenue Next 3Y10.9%
Revenue Next 5YN/A
EBIT growth 1Y-50.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year210.75%
EBIT Next 3Y77.15%
EBIT Next 5YN/A
FCF growth 1Y629.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y410.29%
OCF growth 3YN/A
OCF growth 5YN/A